News
The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...
Despite health authorities issuing fresh guidelines to tackle the growing threat of Chikungunya, action on the ground tells a ...
According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among children under 18.
Chandigarh: Amid a steady rise in dengue and chikungunya cases across the state, the Punjab health department directed all ...
Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...
As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...
Valneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Read what ...
Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine's ...
GlobalData on MSN10d
France halts Valneva’s chikungunya vaccine use in seniorsFrench health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...
Pune: There were concerning complications seen in children during last year's chikungunya outbreak, including one case which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results